Laxmi Organic Industries Limited (LXCHEM)

Loading page…

Laxmi Organic Industries Limited (LXCHEM) · mywealthgrid

About

Laxmi Organic Industries manufactures specialty chemicals serving pharmaceutical, agrochemical, and industrial end-markets. With market capitalization of ₹4,880 crore and quarterly revenue in the ₹700–970 crore range, it operates as a mid-sized player in India's specialty chemicals sector.

Face value: ₹2

Market cap

₹5,028 Cr

P/E

40.0×

P/B

2.5×

Dividend yield

0.2%

ROE

4.1%

ROCE

4.9%

Debt / equity

0.27

OPM

EPS (TTM)

₹4.5

Book value

₹71.6

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Valuation risk: PE of 38.82 stands elevated against reported operating margin of 6.02%, yet stock has underperformed (–4.78% 1-year return); verify whether recent quarterly margin spikes (11.17–11.81% in Jun 2026) represent structural improvement or temporary factors.
Margin volatility: operating margins swung from 5.3% (Sep 2025) to 11.81% (Jun 2026); any reversal would sharply compress earnings given the thin historical baseline.
Low capital efficiency: ROE of 4.08% suggests either capital constraints, low pricing power, or weak demand relative to asset base — verify competitive positioning and asset utilization.
Exposure to cyclical end-markets: specialty chemical demand from pharma, agrochemicals, and industrial sectors varies with cycle; verify customer and product concentration.

Generated analysis · source review pending

Growth drivers

Operating margin expansion from 5.3% (Sep 2025) to 11.81% (Jun 2026) could sustain operating leverage if driven by mix or cost discipline — verify the underlying drivers.
Revenue growth from ₹699–706 Cr (Sep 2025) to ₹957–968 Cr (Jun 2026) would need to persist; verify if sustained or reflects seasonal/cyclical strength.
EPS doubled from ₹0.41–0.51 (Sep 2025) to ₹2.28–2.44 (Jun 2026) as margins expanded — earnings momentum depends on volume and pricing stability.
Consistent dividend payouts (annual, 2022–2026) indicate cash generation; growth in net profit could expand payout capacity and capital deployment for expansion.

Generated analysis · source review pending

1,360 historical price candles were omitted because the exchange source has not been verified.

₹181.4+2.8%1Y

Quick read

rule-based

Pros

+High promoter holding of 69.3% with no pledge

Cons

−Low return on equity of 5.9% (3-yr avg)
−Thin operating margin of 6%
−Profit declined 9% a year over the last 5 years
−Modest revenue growth of 10% a year over the last 5 years
−Low dividend payout of 6.6% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

40/100

Business quality: 24
Growth: 51
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY MICROCAP 250 NIFTY TOTAL MARKET

Screen this industry

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,768	3,084	2,797	2,865	2,985	2,847
COGS	1,174	2,112	1,855	1,925	1,948	1,910
Gross profit	594	972	941	940	1,038	937
	377	604	697	685	758	765
	217	368	245	256	280	171
OPM %	12.3%	11.9%	8.7%	8.9%	9.4%	6%
Depreciation	47	49	72	107	124	77
Interest	16	15	11	7	20	22
	5	15	12	28	25	15
Profit before tax	158	318	173	171	161	88
Tax	31	61	48	50	47	9
Tax %	19.8%	19.3%	27.9%	29.4%	29.3%	9.8%
	127	256	125	121	114	79
PAT margin %	7.2%	8.3%	4.5%	4.2%	3.8%	2.8%
EPS (₹)	5.6	9.7	4.7	4.5	4.1	2.9
EPS adjusted (₹)	4.8	9.7	4.7	4.4	4.1	2.9
	8.9%	7.2%	10.6%	13.5%	12.2%	10.5%
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	45	53	53	53	55	55	55
Reserves	382	982	—	1,359	1,742	1,851	1,930
Minority interest	0	0	—	1	0	0	0
	124	141	—	397	136	253	541
	518	661	—	603	893	884	919
Total equity & liabilities	1,069	1,838	—	2,412	2,827	3,045	3,446
	326	316	379	715	872	1,166	1,481
CWIP	67	148	—	447	444	398	652
Investments	—	—	—	23	126	148	37
	676	1,373	—	1,228	1,385	1,332	1,276
Total assets	1,069	1,838	—	2,412	2,827	3,045	3,446

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	33.6%	31.5%	33.7%	32.8%	34.8%	32.9%
EBITDA margin %	12.3%	11.9%	8.7%	8.9%	9.4%	6%
EBIT margin %	9.6%	10.3%	6.2%	5.2%	5.2%	3.3%
PAT margin %	7.2%	8.3%	4.5%	4.2%	3.8%	2.8%
Working capital
Receivable days	90	—	74	74	66	67
Inventory days	63	—	58	54	71	70
Payable days	148	—	92	145	131	140
NWC days	5	—	41	-16	6	-3
Leverage
Current ratio	1.7	—	1.47	1.66	1.34	1.36
Debt to EBITDA	0.65	—	1.62	0.53	0.91	3.16
Debt to equity	0.14	—	0.28	0.08	0.13	0.27
Interest coverage	10.7	21.6	16.4	27.1	8.8	5
Asset turnover	0.96	—	1.16	1.01	0.98	0.83
Return ratios
Return on assets %	6.9%	—	5.2%	4.3%	3.7%	2.3%
Return on capital employed %	16.3%	—	11.6%	10.1%	9.2%	4.9%
Return on equity %	12.3%	—	8.8%	6.7%	6%	4%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	72.39%	69.83%	69.72%	69.55%	69.5%	69.38%	69.38%	69.37%	69.35%	69.35%	69.35%	69.34%
	0.48%	0.67%	0.85%	1.05%	1.67%	1.97%	2.48%	1.63%	1.6%	1.6%	1.15%	0.69%
	1.56%	3.54%	3.44%	2.16%	3.22%	3.47%	3.38%	4.05%	3.2%	3.39%	3.82%	3.83%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	25.57%	25.96%	25.99%	27.24%	25.61%	25.18%	24.76%	24.95%	25.85%	25.66%	25.68%	26.14%
No. of shareholders	—	—	—	—	—	—	—	—	3,62,107	3,50,899	3,40,436	3,35,793

Promoter holding down 3.05 percentage points since Sep 2023.

18 deals · 12 Aug 2021 – 3 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
3 Jun 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	25,61,699	₹169.26	₹43.36 Cr
3 Jun 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	25,61,699	₹169.18	₹43.34 Cr
3 Jun 2026	BLITZQUANT RESEARCH LLP	Bulk	NSE	Sell	16,71,236	₹169.80	₹28.38 Cr
3 Jun 2026	BLITZQUANT RESEARCH LLP	Bulk	NSE	Buy	16,71,236	₹169.72	₹28.36 Cr
19 Aug 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	16,66,022	₹229.07	₹38.16 Cr
19 Aug 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	16,66,022	₹228.96	₹38.15 Cr
8 Aug 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	14,70,631	₹273.04	₹40.15 Cr
8 Aug 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	14,70,631	₹273.08	₹40.16 Cr
11 Oct 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	21,53,222	₹298.95	₹64.37 Cr
11 Oct 2023	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	21,53,222	₹298.71	₹64.32 Cr

1–10 of 18

1 / 2

Mr. Ravi GoenkaExecutive Director-Chairperson related to Promoter
Mr. Rajan VenkateshExecutive Director-CEO-MD
Mr. Harshvardhan GoenkaExecutive Director
Mr. Rajeev GoenkaNon-Executive - Non Independent Director
Mr. Manish ChokaniNon-Executive - Non Independent Director
Ms. Sangeeta SinghNon-Executive - Independent Director
Mr. Rajeev VaidyaNon-Executive - Independent Director
Mr. Rajiv BanavliNon-Executive - Independent Director
Mr. Arun TodarwalNon-Executive - Independent Director
Mr. Vijay RatnaparkheNon-Executive - Independent Director
Mr. Amit Premchand JainChief Financial Officer

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 3 fund houses

Held by these funds

2.31%

of the company's equity

All mutual funds

3.31%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

5 schemes · 3 fund houses

		Shares
Multi Cap FundNEW	ICICI Prudential Mutual Fund	41.58 L	69.26	0.35%	1.5%	—
Commodities Fund	ICICI Prudential Mutual Fund	20.22 L	33.67	0.79%	0.729%	-0
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	2.2 L	3.66	0.15%	0.079%	-4,809
IB18-Groww Nifty Total Market Index Fund	Groww Mutual Fund	1,503	0.03	0.01%	0.001%	+7
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	247	0	0.01%	0%	+1

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Jul 2026TranscriptAI SummaryPPT REC
May 2026TranscriptAI SummaryPPT REC

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

6

Final dividend21 Jul 2026 · ex-date₹0.3
Final dividend18 Jul 2025 · ex-date₹0.5
Final dividend19 Jul 2024 · ex-date₹0.6
Final dividend21 Jul 2023 · ex-date₹0.5
Final dividend18 Jul 2022 · ex-date₹0.7
Final dividend14 Jul 2021 · ex-date₹0.5

1

Board meeting to consider results29 Jul 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

116 announcementsExport CSV

28 Sept 2026, 2:55 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

8 Sept 2026, 5:57 pmOthers

Board Meeting Outcome for Intimation Of Leadership Transition - Change In Managing Director & Chief Executive Officer

Outcome without intimation PDF

18 Aug 2026, 5:28 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

7 Aug 2026, 5:05 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

31 Jul 2026, 1:06 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

30 Jul 2026, 6:28 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Analyst / Investor Meet PDF

30 Jul 2026, 6:26 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Analyst / Investor Meet PDF

30 Jul 2026, 12:26 pmCompany Update

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Monitoring Agency Report PDF

Date	Category	Subject	Filing
28 Sept 2026, 2:55 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
8 Sept 2026, 5:57 pm	Others Outcome without intimation	Board Meeting Outcome for Intimation Of Leadership Transition - Change In Managing Director & Chief Executive Officer

Loading announcements…

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	33.6%	31.5%	33.7%	32.8%	34.8%	32.9%
EBITDA margin %	12.3%	11.9%	8.7%	8.9%	9.4%	6%
EBIT margin %	9.6%	10.3%	6.2%	5.2%	5.2%	3.3%
PAT margin %	7.2%	8.3%	4.5%	4.2%	3.8%	2.8%
Working capital
Receivable days	90	—	74	74	66	67
Inventory days	63	—	58	54	71	70
Payable days	148	—	92	145	131	140
NWC days	5	—	41	-16	6	-3
Leverage
Current ratio	1.7	—	1.47	1.66	1.34	1.36
Debt to EBITDA	0.65	—	1.62	0.53	0.91	3.16
Debt to equity	0.14	—	0.28	0.08	0.13	0.27
Interest coverage	10.7	21.6	16.4	27.1	8.8	5
Asset turnover	0.96	—	1.16	1.01	0.98	0.83
Return ratios
Return on assets %	6.9%	—	5.2%	4.3%	3.7%	2.3%
Return on capital employed %	16.3%	—	11.6%	10.1%	9.2%	4.9%
Return on equity %	12.3%	—	8.8%	6.7%	6%	4%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	196	123	46	199	562	108	180
	-56	-643	74	-384	-490	-268	-404
	-123	527	-124	232	-42	90	247
Net cash flow	16	6	-5	47	30	-70	24
Free cash flow	—	7	-243	-277	314	-286	-423
CFO / Operating profit %	—	56.5%	12.4%	81.4%	219.6%	38.6%	105%

Laxmi Organic Industries Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

6

1

Announcements

6

1

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Compounded sales growth

Compounded profit growth

Return on equity

Laxmi Organic Industries Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

Dividends6

Board meetings1

Announcements

Dividends6

Board meetings1

Ratio timeline

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

6

1

6

1